Abstract
Gene transcription is tightly regulated at different levels to ensure that the transcriptome of the cell is appropriate for developmental stage and cell type. The chromatin state in which a gene is embedded determines its expression level to a large extent. Activation or repression of transcription is typically accomplished by the recruitment of chromatin-associated multisubunit protein complexes that combine several molecular tools, such as histone-binding and chromatin-modifying activities. Recent biochemical purifications of such complexes have revealed a substantial diversity. On the one hand, complexes that were thought to be unique have been revealed to be part of large complex families. On the other hand, protein subunits that were thought to only exist in separate complexes have been shown to coexist in novel assemblies. In this review we discuss our current knowledge of repressor complexes that contain MBT domain proteins and/or the CoREST co-repressor and use them as a paradigm to illustrate the unexpected heterogeneity and tool sharing of chromatin regulating protein complexes. These recent insights also challenge the ways we define and think about protein complexes in general.
Keywords: complex family, CoREST, MBT protein, protein complex, transcriptional regulation
Abbreviations
- ATP
adenosine triphosphate
- BAP
brahma associated protein
- BHC80
BRAF-histone deacetylase complex 80
- BRG1
brahma Related Gene 1
- CHD
chromo domain helicase DNA binding
- CoREST REST
corepressor
- dL(3)mbt
Drosophila Lethal 3 malignant brain tumor
- DNA
deoxyribonucleic acid
- DNMT
DNA methyltransferase
- DP-1
dimerization partner 1
- ELM2
EGL-27 and MTA1 homology 2
- ES cell
embryonic stem cells
- E2F
E2 transcription Factor
- H
histone
- hBRM
human Brahma
- HDAC
histone deacetylas
- HMTase
histone methylase
- HP1
heterochromatin protein 1
- K
lysine
- Lint-1
l(3)mbt interacting 1
- LINT
l(3)mbt interacting
- LSD1
lysine-specific demethylase 1
- L3MBTL
lethal 3 malignant brain tumor-like
- l(3)mbt
lethal 3 malignant brain tumor
- MBT
malignant brain tumor
- MBTS
malignant brain tumor signature
- NPA1
nucleosome assembly protein
- NRSF
neural-restrictive silencing factor
- NuRD
nucleosome remodeling and deacetylase
- PBAP
polybromo-associated BAP
- Pc
polycomb
- PcG
polycomb group
- Ph
polyhomeotic
- PHD
plant homeo domain
- Pho
pleiohomeotic
- PhoRC
Pho repressive complex
- PRC1
polycomb repressive complex 1
- PRE
polycomb responsive element
- Psc
posterior sex combs
- REST
repressor element 1 silencing transcription factor
- RB
retinoblastoma
- RNA
ribonucleic acid
- Rpd3
reduced potassium dependency 3
- SANT
SWI/ADA2/N-CoR/TFIIIB
- Sce
sex combs extra
- Scm
sex combs on midleg
- SCML
sex combs on midleg-like
- Sfmbt
Scm-related gene containing 4 mbt domains
- SLC
SFMBT1, LSD1, CoREST
- SWH
Salvador-Warts-Hippo
- SWI/SNF
switching defective/sucrose non-fermenting
- TSS
transcription start site
- YY1
ying-yang 1
- ZNF
zinc finger
Introduction
In order to specifically and reliably regulate gene transcription the cell uses multisubunit protein complexes to modulate or maintain chromatin structure. A remarkable feature of these complexes is that they combine several activities to manipulate chromatin. These activities include ATP-dependent nucleosome remodeling, histone modification, DNA modification, DNA and RNA binding, as well as the recognition of specific histone modifications. Typically, each activity is provided by one specific complex subunit, mostly through defined protein domains of this subunit. Multisubunit chromatin regulators can be viewed as “toolboxes” which contain the right combination of “tools” to get a particular chromatin job done. Recently, it is becoming apparent that these complexes are not fixed entities. Complexes that were once thought of as being unique have been revealed to exist in several versions that differ in the precise combination of tools they contain and form “complex families.” Moreover, subunits that were considered to exist in separate complexes have been found together in novel molecular assemblies suggesting that a significant amount of tool sharing is going on. In this review, we will highlight recent findings that illustrate the dynamic nature of the composition and function of multisubunit chromatin regulators.
Evolution of Polymorphic Complexes
SWI/SNF (switching defective/sucrose non-fermenting) complexes are evolutionarily conserved chromatin remodeling complexes that use the energy derived from ATP hydrolysis to modulate chromatin structure.1-3 They provide a good example to illustrate the combinatorial diversity in subunit composition that is characteristic of many chromatin regulating protein complexes of higher organisms. The unicellular yeast Saccharomyces cerevisiae contains a single SWI/SNF complex harboring the SWI2/SNF2 nucleosome remodeling ATPase. This complex has a defined subunit composition.4 Brahma, the homolog of SWI2/SNF2 in the fruit fly Drosophila melanogaster, forms a similar complex.5 However, 2 of its subunits (OSA and Polybromo) associate with Brahma in a mutually exclusive manner. This gives rise to 2 variants of the Brahma complex, BAP and PBAP.6 Humans have 2 highly related but distinct SWI2/SNF2-type ATPases, BRG1 and hBRM, which reside in distinct complexes.7 As in flies, BRG1 shows mutually exclusive interaction with certain subunits resulting in the coexistence of distinct mammalian SWI/SNF complexes.8 The differences in composition and complexity of SWI2/SNF2 assemblies that we observe between unicellular and multicellular organisms likely reflect the diversification of an ancestral monomorphic SWI/SNF complex during evolution (Fig. 1). Such diversification equips the cell with several distinct but related toolboxes that can carry out more specialized functions. Moreover, the polymorphic mammalian SWI/SNF complexes switch subunits as cells undergo differentiation from ES cells to neural progenitor cells and to fully differentiated neurons 9 (Fig. 2, left panel). In analogy to “protein families” these assemblies can be viewed as “protein complex families.”
Figure 1.

Evolution of a protein complex family. Schematic representation of a monomorphic complex (Complex A) that evolves into a family of polymorphic complexes (Complexes A1, A2 and A3).
Figure 2.

Complex families: developmentally regulated cell type-specific expression versus coexistence in the same cell. Scheme illustrating different modes of expression of protein complex family members. Left: Not all members of a protein complex family coexist. Expression of certain subunits is developmentally regulated. As a consequence certain complex family members are only present at particular developmental stages (e.g., SWI/SNF complexes; see text for details). Right: Complex family members coexisting in the same cell type (e.g., PRC1 complexes, see text for details).
Diversity of Function Within Protein Complex families
Another prominent example for a heterogeneous protein complex family is provided by Polycomb group (PcG) proteins. These epigenetic repressors play a critical role during various developmental processes, such as maintenance of cell identity, stem cell differentiation, and cancer development.10,11 To exert their repressive function on chromatin, they assemble into multisubunit protein complexes. One of these complexes is polycomb repressive complex (PRC) 1 that was originally described as a single complex in Drosophila.12 However, in mammals every Drosophila PRC1 subunit is represented by several homologs, providing potential for heterogeneity. Indeed, a combinatorial proteomic and genomic analysis has recently identified 6 major PRC1 complexes (PRC1.1 to PRC1.6) constituting a novel complex family.13 These complexes were all purified from the same cell line demonstrating that they can coexist (Fig. 2, right panel). Why do cells need so many different PRC1 complexes? The answer appears to be that they bring different abilities to the table. While they all share common subunits, each complex also contains a specific set of associated proteins. These additional subunits equip each PRC1 complex with different tools, such as histone demethylation or deacetylation activities and different types of histone modification binding modules.
Merging Protein Complex Families
Sorting the myriad of chromatin regulating complexes neatly into different complex families satisfies the human need for order. However, recent findings suggest that the lines separating protein complex families are becoming increasingly blurred (Fig. 3). This raises fundamental questions about the way we think about and define protein complexes and protein complex families.
Figure 3.

Merging protein complex families. Simplified model of how boundaries between 2 different classes of protein complex families break down as scientific progress (arrow from top to bottom) leads to the identification of novel assemblies. Initially, complex families are defined by the presence of signature subunits (depicted in green/orange or blue/yellow; e.g., MBT domain proteins and CoREST, see text for details). Complex families expand as more complexes are being identified. Some accessory subunits (red) are being found in complexes from both families but the presence of signature subunits still allows an unambiguous classification of complexes. Eventually, complexes are being identified which combine signature subunits from different families. The complex families have merged.
In this review, we will discuss these broader issues by using 2 complex families as examples: MBT domain proteins and complexes containing CoREST proteins 14-19 (Table 1). When MBT and CoREST complexes were originally isolated they were viewed as belonging to distinct families that did not share common subunits (Fig. 3, top panel). Both were proposed to induce repressive chromatin structures but to employ different mechanisms to do so. Unexpectedly, complexes in which MBT domain and CoREST proteins coexist were recently identified.20-23
Table 1.
MBT and CoREST protein complexes. As target genes only major groups of special interest are mentioned. Core subunits are depicted in bold. On the left complexes are labeled according to the presence of MBT and/or CoREST proteins as subunits: MBT protein (blue), CoREST (green) and a combination of MBT and CoREST proteins (red).
| MBT and CoREST complexes | |||||
|---|---|---|---|---|---|
| Name | Subunits | Purification/Material | Target genes | Hypothesized repression mechanism | Ref. |
| Drosophila | |||||
| PRC1 |
Ph Pc Psc Sce/dRing1 dTAFIIs (42, 62, 85, 110, 250) Zeste Scm (?) |
Chromatographic fractionation; affinity purification/Drosophila embryos | Hox genes | H3K27me3 binding (modification set by PRC2); H2AK119 monoubiquitination; chromatin compaction | 52 |
| PhoRC |
Sfmbt Pho |
Tandem affinity purification/Drosophila embryos | Hox genes | PRE binding via Pho; targeting of PRC1 and PRC2 | 27 |
| MybMuvB |
Myb Mip130/120/40 Lin52 E2F2/DP RBF1/2 p55 dL(3)mbt, dRpd3 |
Chromatographic fractionation; affinity purification/Drosophila embryos | Developmentally-regulated E2F target genes | Recruitment of histone modifying co-repressors (e.g., HDAC; HMTs) | 101 |
| dLsd1-dCoREST complex |
dLsd1 dCoREST dRpd3 |
Immunoprecipitation/ SL2 cells |
Neuronal genes | Histone demethylation (H3K4) and deacetylation | 72 |
| LINT |
dL(3)mbt dCoREST dLint-1 |
Flag-affinity purification/SL2 cells | Germline-specific genes | Promoter occupancy and promoter blocking (H4K20me1-independent) | 20 |
| Human (Mammalian) | |||||
| PRC1 |
PHs PCGFs CBXs RING1A/B SCMH1 |
Chromatographic fractionation; affinity purification/ HeLa cells | Hox genes | H2AK119 mono-ubiquitination; chromatin compaction; H3K27me3 binding (modification set by PRC2); | 53 |
| PRC1.1 |
PCGF1SKP1 BcoR/L1 KDM2B |
Tandem affinity purification/HEK293T-REx cells | |||
| PRC1.2/4RING1B/ARYBP or YAF2 | PCGF2/4CBXs PHCs SCMs | ||||
| PRC1.3/5 | PCGF3/5AUTS2 FBRS/L1 CKIIs | ||||
| E2F6.com*/PRC1.6** |
L3MBTL2 E2F6/DP Mga/Max RING1B/A HP1γ YAF2 PCGF6 RYBP**, HDAC1/2**, WDR5 **HMTase1+G9a* |
Tandem affinity purification/HeLa cells *Tandem affinity purification/HEK293T-REx cells** |
E2F target genes | Recruitment of histone modifying co-repressors (e.g., HDAC; HMTs); chromatin compaction | (*)56 (**)13 |
| L3MBTL1 complex |
L3MBTL1 HP1γ pRB H1b core histones |
Affinity purification/ HEK293 cells | E2F target genes | Nucleosome compaction (H4K20 methylation-dependent) |
15 |
| LSD1-CoREST complex |
LSD1 CoREST HDAC1/2 BHC80 BRAF35*/**, CtBP*/ **ZnF217*/**/516*/198 **KIAA0182*, KIAA1343 **HMG20A** |
Affinity purification/HEK293 cells *Tandem affinity purification/HeLa cells** |
Neuronal genes | Histone demethylation (H3K4) and deacetylation | (*)18 (**)19 |
| SLC complex |
SFMBT1 LSD1 CoREST |
Tandem affinity purification/HEK293T-REx cells | Histone house keeping genes | Nucleosome compaction (H4K20methylation-dependent) |
23 |
The MBT Protein Family
The founding member of the MBT protein family is Drosophila Lethal 3 malignant brain tumor (dL(3)mbt).24 A recessive-lethal mutation of the l(3)mbt gene results in malignant transformation of the larval brain.25 Analysis of the dL(3)mbt polypetide sequence revealed 3 tandem repeats of a novel MBT domain.24 In addition to dL(3)mbt, Drosophila encodes 2 more MBT domain proteins with 2 and 4 MBT repeats, respectively: Sex combs on midleg (Scm) and Scm-related gene containing 4 mbt domains (Sfmbt). Both are PcG proteins and thus are required for stable silencing of Hox genes during development.26,27 During evolution the MBT domain protein family has expanded to include 9 members in humans.28 In accordance with the l(3)mbt phenotype in Drosophila several human MBT domain proteins (L3MBTL1, L3MBTL2, L3MBTL3, L3MBTL4, and SCML2) have been implicated in tumorigenesis.28-33
In addition to MBT modules, these proteins often contain zinc fingers and Scm, Ph and MBT homology (SPM) domains.34 The SPM domain mediates oligomerization of MBT domain proteins.35-37
In reporter gene assays, MBT domain proteins function as potent transcriptional repressors when tethered to DNA and the MBT domains appear to play a critical role here.27,38-41 Deletion studies of L3MBTL1 revealed that the 3 MBT domains are essential for full repressive activity.39 Furthermore, the 4 MBT repeats of SFMBT1 are sufficient to mediate transcriptional repression.41
In vitro studies using isolated MBT domains and histone peptides have demonstrated a general preference for binding to mono- or di-methylated, over un- or tri-methylated peptides.27,42-49 An exception to this general rule is provided by the Caenorhabditis elegans protein LIN-61, which displays specificity toward di- and tri-methylated H3K9 histone peptides.50 A recent study investigating the MBT domains of all 9 human family members has found that some MBT domains (L3MBTL1, L3MBTL3) recognize mono- and/or di-methyl-lysine in a promiscuous, non-sequence-specific fashion, whereas others (SCML2, L3MBTL4, MBTD1, L3MBTL2) specifically bind to only a few selected histone sequences.49
Studies focusing on L3MBTL1 and L3MBTL2 have revealed a possible molecular mechanism by which MBT domains could contribute to transcriptional repression. Incubation of the MBT domains of L3MBTL1 or of full-length L3MBTL2 with oligo-nucleosomal arrays results in chromatin compaction in vitro.14,15 Moreover, expression of recombinant full-length SFMBT1 or its MBT domains in cell lines reduces chromatin accessibility to nuclease digestion.23 As we will detail below, MBT domain proteins are found in several multisubunit protein complexes (see Table 1 for a list of MBT and CoREST complexes discussed in this review). They provide these complexes with a tool (the MBT domains) for binding to mono- and di-methylated nucleosomes and for establishing repressive chromatin structures, potentially by way of nucleosome compaction.
MBT Complexes
In Drosophila the MBT domain proteins Scm and Sfmbt are associated with different multisubunit PcG complexes. Drosophila PRC1 contains the core subunits Polycomb (Pc), Polyhomeotic (Ph), Posterior sex combs (Psc) and Sex combs extra (Sce)/Ring1 12,51,52 (Table 1). Several observations suggest that Scm also associates with PRC1 albeit not as a stoichiometric subunit: Biochemical purifications of PRC1 contain substoichiometric amounts of Scm,52,53 Scm interacts with the PRC1 subunit Ph in vitro 37,54 and can stably assemble into a reconstituted PRC1 complex.55 However, co-immunoprecipitations failed to confirm a robust interaction between Scm and PRC1 components and the bulk of Scm in embryo extract separates from Ph in gel filtration analysis.27,55 Nevertheless, Scm repressive activity is sensitive to Ph dosage in reporter gene assays.38 The exact nature of the PRC1-Scm interaction in vivo remains somewhat enigmatic. It is conceivable that this interaction is dynamically regulated, only takes place in certain scenarios, or stably occurs only in the chromatin-bound state.
In mammalian genomes each Drosophila PRC1 subunit is encoded by several homologous genes. This has made it difficult to decipher the composition and molecular function of mammalian PRC1. A comprehensive study has recently identified 6 distinct classes that constitute a multivalent family of human PRC1 13 (Table 1). Each class consists of one of the 6 Pc homologs PCGF1 to PCGF6 (PRC1.1-1.6), H2AK119-specific monoubiquitin-E3-ligases RING1B/A and a specific set of additional factors. Among these complexes PRC1.2 and PRC1.4 contain PCGF1 and PCGF4, respectively, in addition to CBXs (Pc homologs), PHCs (Ph homologs) and the human Scm homologs SCMH1, SCML1 and SCML2 and therefore resemble the canonical Drosophila PRC1 complex, this time with MBT proteins as bona fide subunits. PRC1.6 contains a different MBT protein: L3MBTL2. Additional subunits of PRC1.6 are RING1A/B, the transcription factors E2F6/DP-1 and Mga/Max as well as HP1γ. E2F6/DP-1 and Mga/Max are believed to contribute to targeting the complex to specific sites. An independent study has isolated a very similar assembly incorporating the histone methyltransferases G9a and EuHMTase/GLP as additional subunits.56 PRC1.6 complexes have both been suggested to repress E2F- and Myc-responsive genes in G0 quiescent cells and to repress transcription in actively dividing cells.14,56 Thus, 3 members of the PRC1 complex family are equipped with MBT domains. L3MBTL1 is a component of another complex containing core histones, the linker histone H1B, HP1γ, and the retinoblastoma protein (pRB).15 In line with the pRB association, L3MBTL1 is bound to proximal promoter regions of E2F target genes where its presence contributes to their repression.15,57
In contrast to Drosophila PRC1, canonical PhoRC comprises only 2 subunits, Sfmbt and Pleiohomeotic (Pho) or Pho-like.27 The latter 2 are the only known PcG proteins that contain sequence-specific DNA binding activity and recognize polycomb response elements (PREs).58,59 The closest vertebrate ortholog of Pho is the transcription factor Yin Yang-1 (YY1).60 However, although YY1 and SFMBT2 co-immunoprecipitate upon overexpression in mammalian cells,61 they do not appear to form a stable complex.
Interestingly, a recent purification of Drosophila Sfmbt identified several associated polypeptides in addition to Pho: NAP1, HP1b, Rpd3 and Mga.62 The latter 3 are Drosophila homologs of PRC1.6 subunits.13,56 This indicates that this larger PhoRC assembly (PhoRC-L) resembles human PRC1.6 complexes, but differs in the type of transcription factors targeting it.62
Collectively, MBT complexes appear to function in Polycomb and E2F/Rb repression systems. Interestingly, MBT often coexist with heterochromatin protein 1 γ (HP1γ), core and linker histones. This reinforces the notion that MBT proteins contribute to nucleosome compaction and the formation of heterochromatin.
The CoREST Protein
The human CoREST family comprises 3 related proteins that are encoded by separate genes (CoREST1, CoREST2, and CoREST3). CoREST1 was first identified as an interaction partner and co-repressor protein of the RE1 silencing transcription factor/neural-restrictive silencing factor (REST/NRSF).63 REST is crucial for the restriction of neuronal gene expression by silencing genes via binding to RE-1 elements in non-neuronal tissues.64,65 Unlike MBT proteins, CoREST proteins do not contain a defining signature motif. Instead, they possess an ELM2 (EGL-27 and MTA1 homology 2)66 and 2 SANT (SWI3/ADA2/N-CoR/TFIII-B)67 domains that are shared with several other regulatory chromatin factors. SANT domains frequently act to stimulate histone-modifying enzymes by mediating interactions with their nucleosome substrates.68 ELM2 domains were shown to interact with histone deacetylase in several studies.69-71
CoREST proteins are integral subunits of chromatin modifying complexes that contribute to the generation of repressive chromatin. These conserved complexes combine histone demethylase and deacetylase activities and have been identified in Drosophila,72 C. elegans73,74 and mammals.16-19,75 CoREST1 complexes have been studied most extensively (Table 1). Their core consists of CoREST1, lysine-specific demethylase 1 (LSD1), histone deacetylases 1/2 (HDAC1/2) and the PHD finger protein BHC80. Thus, CoREST1 complexes combine 2 repressive histone modifying activities (LSD1 and HDAC1/2). Additional factors associated with the core that have not been identified in all studies include CtBP, BRAF35 and Zn-finger proteins such as ZNF217 (Table 1). ZNF217, a frequently amplified oncogene, is involved in the negative regulation of the p15ink4b tumor suppressor gene.76 This is accomplished in concert with DNA methyltransferase 3A (DNMT3A), which prevents active DNA demethylation of the locus. This example illustrates that CoREST complexes coordinate several enzymatic activities (histone demethylase, histone deacetylase, DNA methyltransferase) to generate stable repressive chromatin structures.
A recent study revealed that even though CoREST family members CoREST1, CoREST2 and CoREST3 co-purify LSD1 equally well, enzymatic activities of these complexes differ significantly.77,78 Thus, association of LSD1 with CoREST3 leads to diminished catalytic activity, that can antagonize the histone demethylation activity of CoREST1 complexes.77,79 Therefore, it is plausible that the balance between homologous CoREST complexes and the active exchange of CoREST subunits could be important in different scenarios of cellular differentiation.78,79
Structural studies have provided insight into how some of the CoREST complex subunits interact with each other and their chromatin substrate.80-83 Importantly, the LSD1 enzyme alone demethylates H3K4 within peptides or bulk histones in vitro. However, only LSD1 in complex with CoREST is capable of catalyzing H3K4 demethylation within nucleosomes.18,19 Deletion studies revealed that the major stimulatory activity for nucleosome demethylation comprises the second CoREST SANT domain (SANT2) and the linker connecting the 2 SANT domains.19
There are interesting parallels and differences between the functions that MBT domain and CoREST proteins play in their respective complexes. Both proteins are non-enzymatic components of repressive histone-modifying complexes. They both function as tools that directly contact the nucleosome substrates. In the case of MBT proteins, this can have a direct consequence on chromatin structure by promoting nucleosome compaction. In the case of CoREST proteins, the effect is more indirect and stimulates the nucleosome-modifying activities of enzymatic complex subunits.
It is interesting to note that CoREST complexes lower the methylation state of nucleosomes and that MBT proteins preferentially bind to undermethylated (mono- or di-methylated) histone tails. It is tempting to speculate that the action of CoREST complexes increases the affinity of chromatin binding of MBT complexes and that both types of complexes act subsequently. However, as we will discuss in the following section, the link between these complex families can be much more direct.
MBT and CoREST Proteins in Common Complexes
As described above, MBT and CoREST proteins are subunits of distinct protein complex families. However, recent studies in human and Drosophila have identified novel assemblies that combine MBT and CoREST proteins 20-23 (Table 1). Human SFMBT1 was isolated in a complex with LSD1 and CoREST (SLC complex) and the remaining subunits of known CoREST complexes.24 SLC complex subunits are stably associated in both human cells, as well as mouse testes, where SFMBT1 expression levels are highest compared to other tissues.23 The recently identified Drosophila LINT complex also combines MBT and CoREST proteins. LINT has 3 core subunits: dL(3)mbt, dLint-1 (Drosophila L(3)mbt interacting protein-1), and dCoREST and is expressed in cell lines, embryos and larval brain.20 During chromatographic fractionation LINT can be separated from Drosophila dLsd1-containing assemblies. Therefore, LINT, unlike SLC, contains dCoREST disconnected from its usual interaction partner dLsd1. The direct interaction between LSD1 and CoREST and its function in boosting the LSD1 demethylase activity has been well established.82 It remains to be seen what the role of dCoREST within the LINT complex is. It seems likely, that CoREST regardless of the presence or absence of LSD1 facilitates nucleosome binding and may promote a stronger interaction of MBT domains with modified nucleosomes in vivo.
Both SLC and LINT bind preferentially in the vicinity of transcription start sites (TSSs), supporting a major role of both complexes in transcriptional regulation.20,23 Roughly one third of SLC bound targets, are enriched for genes with a function in chromatin and nucleosome assembly, among them replication-dependent histone gene clusters.23 The latter constitute multiple gene copies encoding canonical histones that need to be transcribed efficiently during S-phase.83,84 Interestingly, the occupancy of SLC complex at histone genes appeared to be cell cycle dependent and an enrichment of RNA polymerase II at the promoters during S-phase was accompanied by a loss of all 3 SLC complex components.23 In addition, chromatin binding of SLC to target genes was also developmentally regulated during spermatogenesis.
In flies, 2 studies identified genes that are misexpressed in brain tumors that are caused by l(3)mbtts mutation and contribute to tumorigenic overgrowth.85,86 These genes have been termed malignant brain tumor signature (MBTS) genes.85 A significant proportion of MBTS genes encode proteins with a function in the germline. In addition, a group of target genes downstream of the Salvador-Warts-Hippo (SWH) signaling pathway are upregulated in l(3)mbt mutant brain tumors.86 Chromatin immunoprecipitations reveal a direct binding of LINT subunits to the promoter regions of a majority of MBTS germline and SWH target genes that contribute to tumorigenesis in l(3)mbt mutant larval brains.20,86
Collectively, these studies suggest that complexes combining MBT and CoREST proteins associate with and repress developmentally and cell cycle-regulated genes.
The identification of SLC and LINT weakens the boundaries between MBT-containing PcG complexes and CoREST complexes (Fig. 3). Intriguingly, LSD1 seems to reach out for yet another protein complex family traditionally viewed as separate from both CoREST and PcG complexes: Nucleosome remodeling and histone deacetylase (NuRD) complexes combine the nucleosome remodeling activity of CHD3/CHD4 ATPases with the histone deacetylase activities of HDAC1 and HDAC2. They play important roles in DNA damage repair 87-89 and in generating repressive chromatin environments during development and differentiation.83,86,90,91 NuRD complexes have been the subject of several excellent reviews recently.92-96 LSD1 was found to associate with NuRD subunits in a number of recent studies. This novel assembly functions in the regulation of breast cancer metastasis and in the decommissioning of developmentally regulated enhancers during stem cell differentiation.97-99 These manifold connections between protein complex families once viewed as distinct from one another illustrate the dynamics of versatile protein assemblies that regulate fundamental cellular processes.
Concluding Remarks and Perspectives
In the past decade chromatin regulation in diverse biological processes has been intensively studied. This has unraveled an astounding degree of complexity concerning both the mechanisms and the factors employed. One central theme that has emerged is that chromatin regulators often act in the context of multisubunit protein complexes.
Recent findings suggest that these chromatin regulating complexes - particularly in higher eukaryotes - exist in multiple versions and form complex families instead of single entities. Accordingly, paradigmatic complexes such as PRC1, which were originally viewed as a single entity, have now been revealed to exist in many different versions and to constitute a protein complex family.13,100 Furthermore, variations in the stoichiometry of subunit composition of several of the newly identified complexes indicates that they can be further sub-divided 13,18,19,56 (Table 1). Metaphorically speaking, multisubunit protein complexes function as “toolboxes” which in order to accomplish specific tasks on chromatin combine different “tools” or up-grade their standard equipment by adding specific “tools." For example, distinct PRC1 subcomplexes can couple H2A ubiquitination with various other activities, such as the H3K36me3 and H3K4me3 demethylase activity of KDM2B (in PRC1.1), H3K27me3 binding by CBXs (in PRC1.2/1.4) or chromatin compaction through HP1γ and L3MBTL2 (in PRC1.6). The recently purified SLC and LINT assemblies provide another example of combining different tool sets (MBT domains and CoREST/LSD1) enabling them to use novel strategies to silence genes.
The increasing number of multisubunit protein assemblies that regulate chromatin structure that we have discussed above raises more general questions that go beyond the field of chromatin biology. These questions are not new but in the face of an increasingly overwhelming number of related complexes and subcomplexes they acquire new relevance.
What exactly defines a “complex subunit” as opposed to an associated polypeptide? And to which extent is our use of the term “protein complex” an accurate reflection of the dynamic protein assemblies existing within cells? In the classical, biochemical view protein complex subunits form a stable, interlocking assembly that is resistant to the relatively high salt concentrations commonly used during the purification of protein complexes. However, it is clear that many protocols that are used to lyse cells and tissues and isolate proteins from extracts are prone to disrupt bona fide protein interactions that exist in vivo. In addition, in vivo protein complexes will engage in transient interactions that form and disintegrate continuously.
Many of the apparent discrepancies in the current literature concerning subunit composition and identity of protein complexes might result from differences in the preparation of extracts and purification procedures. In addition, the ever-increasing sensitivity of protein identification by mass spectrometry techniques accounts for the identification of novel subunits that were missed in previous approaches.
Currently, we no longer think of single complexes (e.g., PRC1) but rather of complex families (e.g., PRC1.1-1.6). As the size of these complex families increases and as once distinct protein families merge the classic idea of the protein complex as a defined entity carrying out a defined set of functions becomes less and less useful (Fig. 3). It appears more sensible to think of a continuum of protein complexes whose exact composition and function is dynamic and context-dependent. The protein assemblies that survive our purification regimens are those that are particularly stable and abundant. Undoubtedly, as our purification procedures and protein identification methods become more and more refined we will be able to see more and more of the continuum that currently is still largely hidden from our view.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
We apologize to all colleagues whose work could not be cited due to shortage of space and the limited scope of our article. Work in the lab of A.B. is supported by the DFG (BR 2102/6). We are grateful to members of the F. Recillas-Targa research group for discussion.
Funding
K.M. is supported by a postdoctoral fellowship from the DGAPA-UNAM.
References
- 1. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2SNF2 family necessary for normal mitotic growth and transcription. Nature 1993; 366:170-4; PMID:8232556; http://dx.doi.org/ 10.1038/366170a0 [DOI] [PubMed] [Google Scholar]
- 2. Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR. Nucleosome disruption and enhancement of activator binding by a human SW1SNF complex. Nature 1994; 370:477-81; PMID:8047169; http://dx.doi.org/ 10.1038/370477a0 [DOI] [PubMed] [Google Scholar]
- 3. Peterson CL, Dingwall A, Scott MP. Five SWISNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc Nat Acad Sci USA 1994; 91:2905-8; PMID:8159677; http://dx.doi.org/ 10.1073/pnas.91.8.2905 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem 2009; 78:273-304; PMID:8159677; http://dx.doi.org/ 10.1146/annurev.biochem.77.062706.153223 [DOI] [PubMed] [Google Scholar]
- 5. Dingwall AK, Beek SJ, McCallum CM, Tamkun JW, Kalpana GV, Goff SP, Scott MP. The Drosophila snr1 and brm proteins are related to yeast SWISNF proteins and are components of a large protein complex. Mol Biol Cell 1995; 6:777-91; PMID:7579694; http://dx.doi.org/ 10.1091/mbc.6.7.777 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mohrmann L, Langenberg K, Krijgsveld J, Kal AJ, Heck AJ, Verrijzer CP. Differential targeting of two distinct SWISNF-related Drosophila chromatin-remodeling complexes. Mol Cell Biol 2004; 24:3077-88; PMID:15060132; http://dx.doi.org/ 10.1128/MCB.24.8.3077-3088.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 1996; 15:5370-82; PMID:8895581 [PMC free article] [PubMed] [Google Scholar]
- 8. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. Diversity and specialization of mammalian SWISNF complexes. Genes Dev 1996; 10:2117-30; PMID:8804307; http://dx.doi.org/ 10.1101/gad.10.17.2117 [DOI] [PubMed] [Google Scholar]
- 9. Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, Wu H, Aebersold R, Graef IA, Crabtree GR. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007; 55:201-15; PMID:17640523; http://dx.doi.org/ 10.1016/j.neuron.2007.06.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010; 7:299-313; PMID:20804967; http://dx.doi.org/ 10.1016/j.stem.2010.08.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Aloia L, Di Stefano B, Di Croce L. Polycomb complexes in stem cells and embryonic development. Development 2013; 140:2525-34; PMID:23715546; http://dx.doi.org/ 10.1242/dev.091553 [DOI] [PubMed] [Google Scholar]
- 12. Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu CT, Bender W, Kingston RE. Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 1999; 98:37-46; PMID:10412979; http://dx.doi.org/ 10.1016/S0092-8674(00)80604-2 [DOI] [PubMed] [Google Scholar]
- 13. Gao Z, Zhang J, Bonasio R, Strino F, Sawai A, Parisi F, Kluger Y, Reinberg D. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell 2012; 45:344-56; PMID:22325352; http://dx.doi.org/ 10.1016/j.molcel.2012.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Trojer P, Cao AR, Gao Z, Li Y, Zhang J, Xu X, Li G, Losson R, Erdjument-Bromage H, Tempst P, et al. L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell 2011; 42:438-50; PMID:21596310; http://dx.doi.org/ 10.1016/j.molcel.2011.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Trojer P, Li G, Sims RJ, 3rd, Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, et al. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 2007; 129:915-28; PMID:17540172; http://dx.doi.org/ 10.1016/j.cell.2007.03.048 [DOI] [PubMed] [Google Scholar]
- 16. You A, Tong JK, Grozinger CM, Schreiber SL. CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Nat Acad Sci U S A 2001; 98:1454-8; PMID:11171972; http://dx.doi.org/ 10.1073/pnas.98.4.1454 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hakimi MA, Bochar DA, Chenoweth J, Lane WS, Mandel G, Shiekhattar R. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Nat Acad Sci U S A 2002; 99:7420-5; PMID:12032298; http://dx.doi.org/ 10.1073/pnas.112008599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437:432-5; PMID:16079794 [DOI] [PubMed] [Google Scholar]
- 19. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19:857-64; PMID:16140033; http://dx.doi.org/ 10.1016/j.molcel.2005.08.027 [DOI] [PubMed] [Google Scholar]
- 20. Meier K, Mathieu EL, Finkernagel F, Reuter LM, Scharfe M, Doehlemann G, Jarek M, Brehm A. LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes. PLoS Genet 2012; 8:e1002676; PMID:22570633; http://dx.doi.org/ 10.1371/journal.pgen.1002676 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Lin S, Shen H, Li JL, Tang S, Gu Y, Chen Z, Hu C, Rice JC, Lu J, Wu L. Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program. J Biol Chem 2013; 288:6238-47; PMID:23349461; http://dx.doi.org/ 10.1074/jbc.M112.429605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Tang M, Shen H, Jin Y, Lin T, Cai Q, Pinard MA, Biswas S, Tran Q, Li G, Shenoy AK, et al. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition. J Biol Chem 2013; 288:27680-91; PMID:23928305; http://dx.doi.org/ 10.1074/jbc.M113.482349 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Zhang J, Bonasio R, Strino F, Kluger Y, Holloway JK, Modzelewski AJ, Cohen PE, Reinberg D. SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors. Genes Dev 2013; 27:749-66; PMID:23592795; http://dx.doi.org/ 10.1101/gad.210963.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Wismar J, Loffler T, Habtemichael N, Vef O, Geissen M, Zirwes R, Altmeyer W, Sass H, Gateff E. The Drosophila melanogaster tumor suppressor gene lethal(3)malignant brain tumor encodes a proline-rich protein with a novel zinc finger. Mech Dev 1995; 53:141-54; PMID:8555106; http://dx.doi.org/ 10.1016/0925-4773(95)00431-9 [DOI] [PubMed] [Google Scholar]
- 25. Gateff E, Loffler T, Wismar J. A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: developmental studies and molecular localization of the gene. Mech Dev 1993; 41:15-31; PMID:8507589; http://dx.doi.org/ 10.1016/0925-4773(93)90052-Y [DOI] [PubMed] [Google Scholar]
- 26. Simon J, Chiang A, Bender W. Ten different Polycomb group genes are required for spatial control of the abdA and AbdB homeotic products. Development 1992; 114:493-505; PMID:1350533 [DOI] [PubMed] [Google Scholar]
- 27. Klymenko T, Papp B, Fischle W, Kocher T, Schelder M, Fritsch C, Wild B, Wilm M, Muller J. A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev 2006; 20:1110-22; PMID:16618800; http://dx.doi.org/ 10.1101/gad.377406 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Bonasio R, Lecona E, Reinberg D. MBT domain proteins in development and disease. Semin Cell Dev Biol 2010; 21:221-30; PMID:19778625; http://dx.doi.org/ 10.1016/j.semcdb.2009.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Bench AJ, Li J, Huntly BJ, Delabesse E, Fourouclas N, Hunt AR, Deloukas P, Green AR. Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies. British J Haematol 2004; 127:509-18; PMID:15566354; http://dx.doi.org/ 10.1111/j.1365-2141.2004.05278.x [DOI] [PubMed] [Google Scholar]
- 30. MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells. Genes, Chromosome Cancer 2004; 41:203-13; http://dx.doi.org/ 10.1002/gcc.20087 [DOI] [PubMed] [Google Scholar]
- 31. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009; 41:465-72; PMID:19270706; http://dx.doi.org/ 10.1038/ng.336 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Addou-Klouche L, Adelaide J, Finetti P, Cervera N, Ferrari A, Bekhouche I, Sircoulomb F, Sotiriou C, Viens P, Moulessehoul S, et al. Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer 2010; 9:213; PMID:20698951; http://dx.doi.org/ 10.1186/1476-4598-9-213 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Veigaard C, Norgaard JM, Kjeldsen E. Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases. Cancer Genet 2011; 204:516-21; PMID:22018275; http://dx.doi.org/ 10.1016/j.cancergen.2011.09.002 [DOI] [PubMed] [Google Scholar]
- 34. Bornemann D, Miller E, Simon J. The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein. Development 1996; 122:1621-30; PMID:8625848 [DOI] [PubMed] [Google Scholar]
- 35. Kim CA, Gingery M, Pilpa RM, Bowie JU. The SAM domain of polyhomeotic forms a helical polymer. Nat Struct Biol 2002; 9:453-7; PMID:11992127 [DOI] [PubMed] [Google Scholar]
- 36. Kim CA, Sawaya MR, Cascio D, Kim W, Bowie JU. Structural organization of a Sex-comb-on-midlegpolyhomeotic copolymer. J Biol Chem 2005; 280:27769-75; PMID:15905166; http://dx.doi.org/ 10.1074/jbc.M503055200 [DOI] [PubMed] [Google Scholar]
- 37. Peterson AJ, Kyba M, Bornemann D, Morgan K, Brock HW, Simon J. A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions. Mol Cell Biol 1997; 17:6683-92; PMID:9343432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Roseman RR, Morgan K, Mallin DR, Roberson R, Parnell TJ, Bornemann DJ, Simon JA, Geyer PK. Long-range repression by multiple polycomb group (PcG) proteins targeted by fusion to a defined DNA-binding domain in Drosophila. Genetics 2001; 158:291-307; PMID:11333237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Boccuni P, MacGrogan D, Scandura JM, Nimer SD. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). J Biol Chem 2003; 278:15412-20; PMID:12588862; http://dx.doi.org/ 10.1074/jbc.M300592200 [DOI] [PubMed] [Google Scholar]
- 40. Yoo JY, Choi KC, Kang H, Kim YJ, Lee J, Jun WJ, Kim MJ, Lee YH, Lee OH, Yoon HG. Histone deacetylase 3 is selectively involved in L3MBTL2-mediated transcriptional repression. FEBS Lett 2010; 584:2225-30; PMID:20385135; http://dx.doi.org/ 10.1016/j.febslet.2010.03.048 [DOI] [PubMed] [Google Scholar]
- 41. Wu S, Trievel RC, Rice JC. Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3. FEBS Lett 2007; 581:3289-96; PMID:17599839; http://dx.doi.org/ 10.1016/j.febslet.2007.06.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L, Zhang Y, Bedford MT. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep 2006; 7:397-403; PMID:16415788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Li H, Fischle W, Wang W, Duncan EM, Liang L, Murakami-Ishibe S, Allis CD, Patel DJ. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger. Mol Cell 2007; 28:677-91; PMID:18042461; http://dx.doi.org/ 10.1016/j.molcel.2007.10.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Grimm C, de Ayala Alonso AG, Rybin V, Steuerwald U, Ly-Hartig N, Fischle W, Muller J, Muller CW. Structural and functional analyses of methyl-lysine binding by the malignant brain tumour repeat protein Sex comb on midleg. EMBO Rep 2007; 8:1031-7; PMID:17932512; http://dx.doi.org/ 10.1038/sj.embor.7401085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Min J, Allali-Hassani A, Nady N, Qi C, Ouyang H, Liu Y, MacKenzie F, Vedadi M, Arrowsmith CH. L3MBTL1 recognition of mono- and dimethylated histones. Nat Struct Mol Biol 2007; 14:1229-30; PMID:18026117; http://dx.doi.org/ 10.1038/nsmb1340 [DOI] [PubMed] [Google Scholar]
- 46. Santiveri CM, Lechtenberg BC, Allen MD, Sathyamurthy A, Jaulent AM, Freund SM, Bycroft M. The malignant brain tumor repeats of human SCML2 bind to peptides containing monomethylated lysine. J Mol Biol 2008; 382:1107-12; PMID:18706910; http://dx.doi.org/ 10.1016/j.jmb.2008.07.081 [DOI] [PubMed] [Google Scholar]
- 47. Grimm C, Matos R, Ly-Hartig N, Steuerwald U, Lindner D, Rybin V, Muller J, Muller CW. Molecular recognition of histone lysine methylation by the Polycomb group repressor dSfmbt. EMBO J 2009; 28:1965-77; PMID:19494831; http://dx.doi.org/ 10.1038/emboj.2009.147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Guo Y, Nady N, Qi C, Allali-Hassani A, Zhu H, Pan P, Adams-Cioaba MA, Amaya MF, Dong A, Vedadi M, et al. Methylation-state-specific recognition of histones by the MBT repeat protein L3MBTL2. Nucleic Acids Res 2009; 37:2204-10; PMID:19233876; http://dx.doi.org/ 10.1093/nar/gkp086 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Nady N, Krichevsky L, Zhong N, Duan S, Tempel W, Amaya MF, Ravichandran M, Arrowsmith CH. Histone recognition by human malignant brain tumor domains. J Mol Biol 2012; 423:702-18; PMID:22954662; http://dx.doi.org/ 10.1016/j.jmb.2012.08.022 [DOI] [PubMed] [Google Scholar]
- 50. Koester-Eiserfunke N, Fischle W. H3K9me23 binding of the MBT domain protein LIN-61 is essential for Caenorhabditis elegans vulva development. PLoS Genet 2011; 7:e1002017; PMID:21437264; http://dx.doi.org/ 10.1371/journal.pgen.1002017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Francis NJ, Saurin AJ, Shao Z, Kingston RE. Reconstitution of a functional core polycomb repressive complex. Mol Cell 2001; 8:545-56; PMID:11583617; http://dx.doi.org/ 10.1016/S1097-2765(01)00316-1 [DOI] [PubMed] [Google Scholar]
- 52. Saurin AJ, Shao Z, Erdjument-Bromage H, Tempst P, Kingston RE. A Drosophila Polycomb group complex includes Zeste and dTAFII proteins. Nature 2001; 412:655-60; PMID:11493925; http://dx.doi.org/ 10.1038/35088096 [DOI] [PubMed] [Google Scholar]
- 53. Levine SS, Weiss A, Erdjument-Bromage H, Shao Z, Tempst P, Kingston RE. The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans. Mol Cell Biol 2002; 22:6070-8; PMID:12167701; http://dx.doi.org/ 10.1128/MCB.22.17.6070-6078.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Tomotsune D, Takihara Y, Berger J, Duhl D, Joo S, Kyba M, Shirai M, Ohta H, Matsuda Y, Honda BM, et al. A novel member of murine Polycomb-group proteins, Sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28mph1 in vitro. Diff; Res Biol Divers 1999; 65:229-39; PMID:10653359; http://dx.doi.org/ 10.1046/j.1432-0436.1999.6540229.x [DOI] [PubMed] [Google Scholar]
- 55. Peterson AJ, Mallin DR, Francis NJ, Ketel CS, Stamm J, Voeller RK, Kingston RE, Simon JA. Requirement for sex comb on midleg protein interactions in Drosophila polycomb group repression. Genetics 2004; 167:1225-39; PMID:15280237; http://dx.doi.org/ 10.1534/genetics.104.027474 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 2002; 296:1132-6; PMID:12004135; http://dx.doi.org/ 10.1126/science.1069861 [DOI] [PubMed] [Google Scholar]
- 57. Kalakonda N, Fischle W, Boccuni P, Gurvich N, Hoya-Arias R, Zhao X, Miyata Y, Macgrogan D, Zhang J, Sims JK, et al. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 2008; 27:4293-304; PMID:18408754; http://dx.doi.org/ 10.1038/onc.2008.67 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Brown JL, Fritsch C, Mueller J, Kassis JA. The Drosophila pho-like gene encodes a YY1-related DNA binding protein that is redundant with pleiohomeotic in homeotic gene silencing. Development 2003; 130:285-94; PMID:12466196; http://dx.doi.org/ 10.1242/dev.00204 [DOI] [PubMed] [Google Scholar]
- 59. Brown JL, Mucci D, Whiteley M, Dirksen ML, Kassis JA. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell 1998; 1:1057-64; PMID:9651589; http://dx.doi.org/ 10.1016/S1097-2765(00)80106-9 [DOI] [PubMed] [Google Scholar]
- 60. Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991; 67:377-88; PMID:1655281; http://dx.doi.org/ 10.1016/0092-8674(91)90189-6 [DOI] [PubMed] [Google Scholar]
- 61. Kuzmin A, Han Z, Golding MC, Mann MR, Latham KE, Varmuza S. The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. Gene Expr Patterns: GEP 2008; 8:107-16; PMID:18024232; http://dx.doi.org/ 10.1016/j.modgep.2007.09.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Alfieri C, Gambetta MC, Matos R, Glatt S, Sehr P, Fraterman S, Wilm M, Muller J, Muller CW. Structural basis for targeting the chromatin repressor Sfmbt to Polycomb response elements. Genes Dev 2013; 27:2367-79; PMID:24186981; http://dx.doi.org/ 10.1101/gad.226621.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Andres ME, Burger C, Peral-Rubio MJ, Battaglioli E, Anderson ME, Grimes J, Dallman J, Ballas N, Mandel G. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Nat Acad Sci U S A 1999; 96:9873-8; PMID:10449787; http://dx.doi.org/ 10.1073/pnas.96.17.9873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC, Altshuller YM, Frohman MA, Kraner SD, Mandel G. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 1995; 80:949-57; PMID:7697725; http://dx.doi.org/ 10.1016/0092-8674(95)90298-8 [DOI] [PubMed] [Google Scholar]
- 65. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 1995; 267:1360-3; PMID:7871435; http://dx.doi.org/ 10.1126/science.7871435 [DOI] [PubMed] [Google Scholar]
- 66. Solari F, Bateman A, Ahringer J. The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development 1999; 126:2483-94; PMID:10226007 [DOI] [PubMed] [Google Scholar]
- 67. Aasland R, Stewart AF, Gibson T. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci 1996; 21:87-8; PMID:8882580 [PubMed] [Google Scholar]
- 68. Boyer LA, Latek RR, Peterson CL. The SANT domain: a unique histone-tail-binding module? Nat Rev Mol Cell Biol 2004; 5:158-63; PMID:15040448; http://dx.doi.org/ 10.1038/nrm1314 [DOI] [PubMed] [Google Scholar]
- 69. Ding Z, Gillespie LL, Paterno GD. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. Mol Cell Biol 2003; 23:250-8; PMID:12482978; http://dx.doi.org/ 10.1128/MCB.23.1.250-258.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Wang L, Rajan H, Pitman JL, McKeown M, Tsai CC. Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. Genes Dev 2006; 20:525-30; PMID:16481466; http://dx.doi.org/ 10.1101/gad.1393506 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Millard CJ, Watson PJ, Celardo I, Gordiyenko Y, Cowley SM, Robinson CV, Fairall L, Schwabe JW. Class I HDACs share a common mechanism of regulation by inositol phosphates. Mol Cell 2013; 51:57-67; PMID:23791785; http://dx.doi.org/ 10.1016/j.molcel.2013.05.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Dallman JE, Allopenna J, Bassett A, Travers A, Mandel G. A conserved role but different partners for the transcriptional corepressor CoREST in fly and mammalian nervous system formation. J Neurosci: Off J Soc Neurosci 2004; 24:7186-93; PMID:15306652; http://dx.doi.org/ 10.1523/JNEUROSCI.0238-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Smialowska A, Baumeister R. Presenilin function in Caenorhabditis elegans. Neuro-Degenerative Dis 2006; 3:227-32; PMID:17047361; http://dx.doi.org/ 10.1159/000095260 [DOI] [PubMed] [Google Scholar]
- 74. Jarriault S, Greenwald I. Suppressors of the egg-laying defective phenotype of sel-12 presenilin mutants implicate the CoREST corepressor complex in LIN-12Notch signaling in C. elegans. Genes Dev 2002; 16:2713-28; PMID:12381669; http://dx.doi.org/ 10.1101/gad.1022402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Cowger JJ, Zhao Q, Isovic M, Torchia J. Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence. Oncogene 2007; 26:3378-86; PMID:17130829; http://dx.doi.org/ 10.1038/sj.onc.1210126 [DOI] [PubMed] [Google Scholar]
- 76. Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, Torchia J. TGF-beta-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217CoREST complex. Mol Cell 2012; 46:636-49; PMID:22560925; http://dx.doi.org/ 10.1016/j.molcel.2012.03.027 [DOI] [PubMed] [Google Scholar]
- 77. Barrios AP, Gomez AV, Saez JE, Ciossani G, Toffolo E, Battaglioli E, Mattevi A, Andres ME. Differential properties of transcriptional complexes formed by the CoREST family. Mol Cell Biol 2014; 34:2760-70; PMID:24820421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Yang P, Wang Y, Chen J, Li H, Kang L, Zhang Y, Chen S, Zhu B, Gao S. RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency. Stem Cells 2011; 29:791-801; PMID:21433225; http://dx.doi.org/ 10.1002/stem.634 [DOI] [PubMed] [Google Scholar]
- 79. Upadhyay G, Chowdhury AH, Vaidyanathan B, Kim D, Saleque S. Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation. Proc Nat Acad Sci U S A 2014; 111:8071-6; PMID:24843136; http://dx.doi.org/ 10.1073/pnas.1404292111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Chen Y, Yang Y, Wang F, Wan K, Yamane K, Zhang Y, Lei M. Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc Nat Acad Sci U S A 2006; 103:13956-61; PMID:16956976; http://dx.doi.org/ 10.1073/pnas.0606381103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Baron R, Vellore NA. LSD1CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition. Proc Nat Acad Sci U S A 2012; 109:12509-14; PMID:22802671; http://dx.doi.org/ 10.1073/pnas.1207892109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Yang M, Gocke CB, Luo X, Borek D, Tomchick DR, Machius M, Otwinowski Z, Yu H. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol Cell 2006; 23:377-87; PMID:16885027; http://dx.doi.org/ 10.1016/j.molcel.2006.07.012 [DOI] [PubMed] [Google Scholar]
- 83. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Zaidi SK, Braastad C. An architectural perspective of cell-cycle control at the G1S phase cell-cycle transition. J Cell Physiol 2006; 209:706-10; PMID:17001681; http://dx.doi.org/ 10.1002/jcp.20843 [DOI] [PubMed] [Google Scholar]
- 84. Marzluff WF, Wagner EJ, Duronio RJ. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet 2008; 9:843-54; PMID:18927579; http://dx.doi.org/ 10.1038/nrg2438 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 2010; 330:1824-7; PMID:21205669; http://dx.doi.org/ 10.1126/science.1195481 [DOI] [PubMed] [Google Scholar]
- 86. Richter C, Oktaba K, Steinmann J, Muller J, Knoblich JA. The tumour suppressor L(3)mbt inhibits neuroepithelial proliferation and acts on insulator elements. Nat Cell Biol 2011; 13:1029-39; PMID:21857667; http://dx.doi.org/ 10.1038/ncb2306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Polo SE, Kaidi A, Baskcomb L, Galanty Y, Jackson SP. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4. EMBO J 2010; 29:3130-9; PMID:20693977; http://dx.doi.org/ 10.1038/emboj.2010.188 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Smeenk G, Wiegant WW, Vrolijk H, Solari AP, Pastink A, van Attikum H. The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage. J Cell Biol 2010; 190:741-9; PMID:20805320; http://dx.doi.org/ 10.1083/jcb.201001048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc Nat Acad Sci USA 2010; 107:18475-80; PMID:20937877; http://dx.doi.org/ 10.1073/pnas.1012946107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Reynolds N, Latos P, Hynes-Allen A, Loos R, Leaford D, O’Shaughnessy A, Mosaku O, Signolet J, Brennecke P, Kalkan T, et al. NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 2012; 10:583-94; PMID:22560079; http://dx.doi.org/ 10.1016/j.stem.2012.02.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA. MTA3 and the Mi-2NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 2004; 119:75-86; PMID:15454082; http://dx.doi.org/ 10.1016/j.cell.2004.09.014 [DOI] [PubMed] [Google Scholar]
- 92. Lai AY, Wade PA. Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nat Rev Cancer 2011; 11:588-96; PMID:21734722; http://dx.doi.org/ 10.1038/nrc3091 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Hu G, Wade PA. NuRD and pluripotency: a complex balancing act. Cell Stem Cell 2012; 10:497-503; PMID:22560073; http://dx.doi.org/ 10.1016/j.stem.2012.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. O’Shaughnessy A, Hendrich B. CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now. Biochem Soc Trans 2013; 41:777-82; http://dx.doi.org/ 10.1042/BST20130027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Basta J, Rauchman M. The nucleosome remodeling and deacetylase complex in development and disease. Trans Res: J Lab Clin Med 2014; S1931-5244:00166-2; PMID:24880148; http://dx.doi.org/ 10.1016/j.trsl.2014.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Laugesen A, Helin K. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 2014; 14:735-51; PMID:24905164; http://dx.doi.org/ 10.1016/j.stem.2014.05.006 [DOI] [PubMed] [Google Scholar]
- 97. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009; 138:660-72; PMID:19703393; http://dx.doi.org/ 10.1016/j.cell.2009.05.050 [DOI] [PubMed] [Google Scholar]
- 98. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT, Cowley SM, Young RA. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012; 482:221-5; PMID:22297846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Nair SS, Li DQ, Kumar R. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol Cell 2013; 49:704-18; PMID:23352453; http://dx.doi.org/ 10.1016/j.molcel.2012.12.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Vandamme J, Volkel P, Rosnoblet C, Le Faou P, Angrand PO. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Mol Cell Proteomics: MCP 2011; 10:M110 002642; http://dx.doi.org/ 10.1074/mcp.M110.002642 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, Botchan MR. Identification of a Drosophila Myb-E2F2RBF transcriptional repressor complex. Genes Dev 2004; 18:2929-40; PMID:15545624; http://dx.doi.org/ 10.1101/gad.1255204 [DOI] [PMC free article] [PubMed] [Google Scholar]
